NEOGENOMICS INC
NEOGENOMICS INC
Hinterlegungsschein · US64049M2098 · NEO · 120159 (XNCM)
Übersicht
7,80 USD
3,17 % 0,24 USD
NASDAQ CAPITAL MARKET (XNAS) · Aktuelle Kurse und Charts bei MoneyPeak
10.06.2025 21:03

Aktuelle Kurse von NEOGENOMICS INC

BörseTickerWährungLetzter UmsatzKursTagesveränderung
XNAS: NASDAQ
NASDAQ
NEO
USD
10.06.2025 21:03
7,80 USD
7,56 USD
+3,17 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
0,00 % 5,69 % -3,11 % -14,14 % -57,68 % -41,44 % -71,74 %

Company Profile for NEOGENOMICS INC Depository Receipt

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. The company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization, as well as acts as a reference laboratory supplying anatomic pathology testing services. It has a strategic alliance agreement and laboratory services agreement with Inivata Limited. The company was founded in 2001 and is headquartered in Fort Myers, Florida.

Company Data

Name NEOGENOMICS INC
Company NeoGenomics, Inc.
Symbol NEO
Website https://www.neogenomics.com
Primary Exchange XNCM NASDAQ CAPITAL MARKET
WKN 120159
ISIN US64049M2098
Asset Class Depository Receipt
Sector Healthcare
Industry Medical - Diagnostics & Research
CEO Mr. Anthony P. Zook
Market Capitalization 1 Mrd.
Country United States of America
Currency USD
Employees 2,2 T
Address 9490 NeoGenomics Way, 33912 Fort Myers
IPO Date 2004-03-16
Dividends from 'NEOGENOMICS INC'
Ex-Date Dividend per Share
17.12.2020 0,40 USD

ID Changes

Date From To
17.12.2012 NGNM NEO

Ticker Symbols

Name Symbol
Frankfurt NG9.F
NASDAQ NEO

More Shares

Investors who NEOGENOMICS INC hold also have the following shares in their portfolio:
AMGEN INC
AMGEN INC Share
AMUNDI FUNDS PIONEER US EQUITY FUNDAMENTAL GROWTH - I2 EUR HGD AD (D)
AMUNDI FUNDS PIONEER US EQUITY FUNDAMENTAL GROWTH - I2 EUR HGD AD (D) ETF
ASTRAZENECA PLC
ASTRAZENECA PLC Share
AUTODESK INC
AUTODESK INC Share
BIOGEN INC
BIOGEN INC Share
CISCO SYSTEMS INC
CISCO SYSTEMS INC Share
COSTCO WHOLESALE CORP
COSTCO WHOLESALE CORP Share
EBAY INC
EBAY INC Share
ESSEX PROPERTY TRUST
ESSEX PROPERTY TRUST Fund
INTEL CORP
INTEL CORP Share
MICROSOFT CORP
MICROSOFT CORP Share
O'REILLY AUTOMOTIVE INC
O'REILLY AUTOMOTIVE INC Share
PHILIPPINEN 22/32
PHILIPPINEN 22/32 Bond
WALGREENS BOOTS ALLIANCE INC
WALGREENS BOOTS ALLIANCE INC Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025